Cargando…

Epidemiology, aetiology and screening of bladder cancer

Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industrialized regions and the most responsible carcinogens...

Descripción completa

Detalles Bibliográficos
Autores principales: Cumberbatch, Marcus G. K., Noon, Aidan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414346/
https://www.ncbi.nlm.nih.gov/pubmed/30976562
http://dx.doi.org/10.21037/tau.2018.09.11
_version_ 1783402960598859776
author Cumberbatch, Marcus G. K.
Noon, Aidan P.
author_facet Cumberbatch, Marcus G. K.
Noon, Aidan P.
author_sort Cumberbatch, Marcus G. K.
collection PubMed
description Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industrialized regions and the most responsible carcinogens are tobacco smoke and occupational chemical exposure. BC incidence and mortality differ dramatically by region and reflect differences in risk factor exposure, healthcare behaviour, and population demographics. Screening studies have suggested a survival benefit amongst screened non-symptomatic populations with known risk factors, but this has not become standard practice.
format Online
Article
Text
id pubmed-6414346
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-64143462019-04-11 Epidemiology, aetiology and screening of bladder cancer Cumberbatch, Marcus G. K. Noon, Aidan P. Transl Androl Urol Review Article Bladder cancer (BC) is a common, significant and expensive health condition. Understanding the risk factors for this disease is paramount to improving disease prevention and increasing public awareness. Historically BC has been a disease of industrialized regions and the most responsible carcinogens are tobacco smoke and occupational chemical exposure. BC incidence and mortality differ dramatically by region and reflect differences in risk factor exposure, healthcare behaviour, and population demographics. Screening studies have suggested a survival benefit amongst screened non-symptomatic populations with known risk factors, but this has not become standard practice. AME Publishing Company 2019-02 /pmc/articles/PMC6414346/ /pubmed/30976562 http://dx.doi.org/10.21037/tau.2018.09.11 Text en 2019 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
Cumberbatch, Marcus G. K.
Noon, Aidan P.
Epidemiology, aetiology and screening of bladder cancer
title Epidemiology, aetiology and screening of bladder cancer
title_full Epidemiology, aetiology and screening of bladder cancer
title_fullStr Epidemiology, aetiology and screening of bladder cancer
title_full_unstemmed Epidemiology, aetiology and screening of bladder cancer
title_short Epidemiology, aetiology and screening of bladder cancer
title_sort epidemiology, aetiology and screening of bladder cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414346/
https://www.ncbi.nlm.nih.gov/pubmed/30976562
http://dx.doi.org/10.21037/tau.2018.09.11
work_keys_str_mv AT cumberbatchmarcusgk epidemiologyaetiologyandscreeningofbladdercancer
AT noonaidanp epidemiologyaetiologyandscreeningofbladdercancer